↓ Skip to main content

PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer

Overview of attention for article published in Frontiers in oncology, June 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
78 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer
Published in
Frontiers in oncology, June 2019
DOI 10.3389/fonc.2019.00462
Pubmed ID
Authors

Michiel Remmerie, Veerle Janssens

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 78 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 17%
Student > Ph. D. Student 11 14%
Student > Master 6 8%
Student > Bachelor 5 6%
Student > Doctoral Student 4 5%
Other 11 14%
Unknown 28 36%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 19 24%
Agricultural and Biological Sciences 9 12%
Medicine and Dentistry 6 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Computer Science 3 4%
Other 4 5%
Unknown 34 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 July 2019.
All research outputs
#15,100,333
of 25,385,509 outputs
Outputs from Frontiers in oncology
#4,421
of 22,432 outputs
Outputs of similar age
#188,783
of 366,665 outputs
Outputs of similar age from Frontiers in oncology
#95
of 289 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,432 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,665 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 289 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.